Madhav V. Dhodapkar, MBBS
Arthur H. and Isabel Bunker Professor of Medicine (Hematology) and Professor of Immunobiology; Chief, Section of Hematology, Department of Internal Medicine; Director of Hematologic Malignancies, Yale Cancer Center

Departments & Organizations
Biological and Biomedical Sciences (BBS): Immunology | Molecular Medicine, Pharmacology, and PhysiologyYale Medical Group
Cancer Center, Yale: Hematology Program | Cancer Immunology
Immunobiology
Hematology
Biography
Medical School: All India Instt. of Medical Sciences, New Delhi, IndiaFellowship (Hematology / Oncology): Mayo Clinic, Rochester, MN
Prior Faculty appointments: Myeloma Institute, Little Rock, AR; Memorial Sloan Kettering Cancer Center, New York, NY; The Rockefeller University, New York, NY
Research Interests: Immunobiology of myeloma; Development of novel biological approaches to treat cancer; dendritic cell biology
Education
- M.B.B.S., All India Institute of Medical Sciences, New Delhi, 1987
Selected Publication
- Dhodapkar K, Banerjee D, Connolly J, Kukreja A, Matayeva E, Veri MC, Ravetch JV, Steinman RM, Dhodapkar MV. Selective blockade of the inhibitory FC? receptor (Fc?RIIB) in human dendritic cells and monocytes induces a type I interferon response program. J Exp Med. 2007, 204: 1359-1369.
Articles
May/June 2010
Immune system fights stem cells’ dark side
If proteins were celebrities, OCT4 would be on the A-list. In 2007, in a dramatic advance, several researchers showed...

May/June 2008
Expert on myeloma, cancer vaccines to head hematology
Madhav V. Dhodapkar, M.D., an expert on multiple myeloma and monoclonal gammopathy of unknown significance (MGUS), the...


